Analyst Ratings for Amneal Pharmaceuticals (AMRX)
AMRX Rating Summary
AMRX Price Target Summary
- Highest: $25.00 (UBS)
- Lowest: $13.00 (Piper Sandler)
- Average: $18.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$18.67 (+10.5%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 61%
Avg. $ Target:
$18.67 (+10.5%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 61%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | Leerink | Daniel Clark | New Coverage | Outperform (N/A) |
23.00 (N/A) |
17.05 (16.90) |
-0.88% | Details |
| 8/24/2026 | DA Davidson | Garik Shmois | New Coverage | Neutral (N/A) |
N/A (N/A) |
17.91 (16.90) |
-5.64% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
